A citation-based method for searching scientific literature

Till Seuring, Olga Archangelidi, Marc Suhrcke. Pharmacoeconomics 2015
Times Cited: 353







List of co-cited articles
274 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
9

The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
Christian Bommer, Esther Heesemann, Vera Sagalova, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Sebastian Vollmer. Lancet Diabetes Endocrinol 2017
278
8

Type 2 diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Lancet 2017
770
7


Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
Sarah Wild, Gojka Roglic, Anders Green, Richard Sicree, Hilary King. Diabetes Care 2004
6

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
6

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.
Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
6


IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
5

Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
Manel Mata-Cases, Marc Casajuana, Josep Franch-Nadal, Aina Casellas, Conxa Castell, Irene Vinagre, Dídac Mauricio, Bonaventura Bolíbar. Eur J Health Econ 2016
53
9

Cost-of-illness studies of diabetes mellitus: a systematic review.
Charmaine S Ng, Joyce Y C Lee, Matthias Phs Toh, Yu Ko. Diabetes Res Clin Pract 2014
65
7

Prevalence and control of diabetes in Chinese adults.
Yu Xu, Limin Wang, Jiang He, Yufang Bi, Mian Li, Tiange Wang, Linhong Wang, Yong Jiang, Meng Dai, Jieli Lu,[...]. JAMA 2013
5

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
5

Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
Christian Bommer, Vera Sagalova, Esther Heesemann, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Justine Davies, Sebastian Vollmer. Diabetes Care 2018
305
5

Type 2 diabetes and quality of life.
Aikaterini Trikkalinou, Athanasia K Papazafiropoulou, Andreas Melidonis. World J Diabetes 2017
166
5

Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies.
Susanne Ulrich, Rolf Holle, Margarethe Wacker, Renee Stark, Andrea Icks, Barbara Thorand, Annette Peters, Michael Laxy. BMJ Open 2016
33
15

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
5


Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
570
4

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
4

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
4

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
K Ogurtsova, J D da Rocha Fernandes, Y Huang, U Linnenkamp, L Guariguata, N H Cho, D Cavan, J E Shaw, L E Makaroff. Diabetes Res Clin Pract 2017
4

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
4



Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.
Moien Abdul Basith Khan, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, Juma Al Kaabi. J Epidemiol Glob Health 2020
250
4

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
355
3

Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany.
Katharina Kähm, Michael Laxy, Udo Schneider, Wolf H Rogowski, Stefan K Lhachimi, Rolf Holle. Diabetes Care 2018
54
5

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
Philip M Clarke, Paul Glasziou, Anushka Patel, John Chalmers, Mark Woodward, Stephen B Harrap, Joshua A Salomon. PLoS Med 2010
96
3

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
3



Role of self-care in management of diabetes mellitus.
Saurabh Rambiharilal Shrivastava, Prateek Saurabh Shrivastava, Jegadeesh Ramasamy. J Diabetes Metab Disord 2013
304
3

Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.
Charlene C Quinn, Michelle D Shardell, Michael L Terrin, Erik A Barr, Shoshana H Ballew, Ann L Gruber-Baldini. Diabetes Care 2011
376
3

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.
David R Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw. Diabetes Res Clin Pract 2011
3

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
779
3

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
3

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
3


The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.
Lei Chen, Dianna J Magliano, Paul Z Zimmet. Nat Rev Endocrinol 2011
3

Adherence to therapies in patients with type 2 diabetes.
Luis-Emilio García-Pérez, María Alvarez, Tatiana Dilla, Vicente Gil-Guillén, Domingo Orozco-Beltrán. Diabetes Ther 2013
342
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
3

Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes.
Maria I Constantino, Lynda Molyneaux, Franziska Limacher-Gisler, Abdulghani Al-Saeed, Connie Luo, Ted Wu, Stephen M Twigg, Dennis K Yue, Jencia Wong. Diabetes Care 2013
234
3

The economic burden of diabetes.
Timothy M Dall, Yiduo Zhang, Yaozhu J Chen, William W Quick, Wenya G Yang, Jeanene Fogli. Health Aff (Millwood) 2010
185
3

Medication adherence and glycemic control among newly diagnosed diabetes patients.
Lee-Kai Lin, Yan Sun, Bee Hoon Heng, Daniel Ek Kwang Chew, Phui-Nah Chong. BMJ Open Diabetes Res Care 2017
33
9

Projected number of people with diagnosed Type 2 diabetes in Germany in 2040.
T Tönnies, S Röckl, A Hoyer, C Heidemann, J Baumert, Y Du, C Scheidt-Nave, R Brinks. Diabet Med 2019
32
9

Healthcare costs of Type 2 diabetes in Germany.
E Jacobs, A Hoyer, R Brinks, A Icks, O Kuß, W Rathmann. Diabet Med 2017
36
8

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin, M Stampfer,[...]. Lancet 2010
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.